The WA cross-idiotype (XId) is the major XId among human monoclonal rheumatoid factors (mRF) and is almost always associated with the light (L) chain XId, 17.109, and the heavy (H) chain XId, G6. A cell line, 35G6, was cloned that bears the WA XId, but shows no reactivity with immunoglobulin G (IgG) and is negative for the 17.109 and G6 XIds. The 35G6 L chain appears to be derived from the same VKIII-JKI genes as most WA mRFs L chains. In contrast to the WA mRFs H chains in which VH1 genes are used, the 35G6 IgM expresses a VH3 gene. Sequence comparisons with other WA XId-positive mRF suggested several common structural features that may be related to the WA XId and differences that may relate to lack of IgG reactivity. Cells similar to 35G6 have previously been described in pokeweed mitogen-stimulated cell lines of peripheral blood lymphocytes from normal individuals and patients with rheumatoid arthritis and type II mixed cryoglobulinemia. These observations were confirmed, and in addition, it was shown that the majority of WA XId-positive cells in these cultures were negative for the 17.109 and G6 XIds. The presence of the WA XId in the absence of IgG reactivity suggests that the WA XId is more directly associated with an antigen specificity other than IgG, and its association with RF activity may be incidental. It is postulated that these WA XId-positive RF-negative antibodies may serve a physiologic role as natural antibodies to a pervasive pathogen, and that IgG reactivity is a consequence of somatic diversification accompanying proliferation of the WA XId-positive RF-negative cell.
Skip Nav Destination
Article navigation
1 December 1993
Article|
December 01 1993
Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds.
G B Knight,
G B Knight
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Search for other works by this author on:
V Agnello,
V Agnello
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Search for other works by this author on:
V Bonagura,
V Bonagura
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Search for other works by this author on:
J L Barnes,
J L Barnes
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Search for other works by this author on:
D J Panka,
D J Panka
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Search for other works by this author on:
Q X Zhang
Q X Zhang
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Search for other works by this author on:
G B Knight
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
V Agnello
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
V Bonagura
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
J L Barnes
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
D J Panka
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Q X Zhang
Department of Laboratory Medicine, Lahey Clinic, Burlington, Massachusetts 01805.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 178 (6): 1903–1911.
Citation
G B Knight, V Agnello, V Bonagura, J L Barnes, D J Panka, Q X Zhang; Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds.. J Exp Med 1 December 1993; 178 (6): 1903–1911. doi: https://doi.org/10.1084/jem.178.6.1903
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement